Novo Nordisk’s Buyback Blitz Runs Alongside a Parent’s Billion-Dollar Exit
The Danish pharma heavyweight is keeping its share repurchase engine running at full throttle — and the timing…
Novo Nordisk’s Billion-Dollar Buyback Meets a Pricing Squeeze and Digital Dominance in Obesity Marke
Novo Nordisk repurchases billions in B-shares amid 44% stock drop, buoyed by strong Wegovy sales and a digital…
European Lithium’s Billion-Dollar Bet Awaits Greenland’s Green Light
European Lithium launches a major buyback, betting on its undervalued stake in Critical Metals Corp and the blocked…